Analysts’ expectations for Intellia Therapeutics Inc (NTLA) stock: $28.25 price target in 12 months
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $7.41, up 9.45%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NTLA shares have gain 11.76% over the last week, with a monthly amount drifted -19.63%, and not seem to […]
Analysts predict Intellia Therapeutics Inc (NTLA) stock to reach $28.25 in the next 12 months
Intellia Therapeutics Inc [NTLA] stock is trading at $6.28, down -3.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NTLA shares have lost -5.63% over the last week, with a monthly amount drifted -33.62%, and not seem to be holding up […]
Is that what Sustainable Earning stands for?: Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Inc [NTLA] stock is trading at $9.30, down -1.69%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NTLA shares have gain 2.25% over the last week, with a monthly amount drifted -5.01%, and not seem to be holding up well over […]
It’s still a bull thesis, just subverted: Intellia Therapeutics Inc (NTLA)
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $12.17, down -0.65%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NTLA shares have gain 26.24% over the last week, with a monthly amount glided 10.54%, and seem […]
